Litenimod
利尼莫德
Report date: 2023/04/21 16:05:22
NME
Base Information
Drug NameLitenimod
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A